Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxyfilline in Major Liver Resection
NCT00957619Phase 4Completed
- Sponsor
- University of Zurich
- Start
- Mar 2006
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in reperfusion injury (IRI) and liver regeneration comparing pentoxyfilline group with placebo group (2 arms). Primary endpoint: Regeneration of the liver after liver resection. Started Mar 2006; status: completed.
02
Drugs
pentoxifylline
03
Conditions
reperfusion injury (IRI)liver regeneration
Beyond the preview
Go deeper on NCT00957619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00957619.